Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Looking for quick cash without a job? Discover various ways to receive cash today without work and boost your finances effortlessly.
25,802 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As markets digest a high-stakes political address and evolving risk appetite, bitcoin nudges higher. Traders balance ...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
A powerful rally in spacex stock surged again today, led by a game-changing AI acquisition and strong market momentum...
Google bought YouTube for $1.65 billion in 2006. The founders walked away with hundreds of millions, and today YouTub...
A bold move from SpaceX has investors weighing risk and reward. This guide breaks down what the decision could mean f...
Investors are buzzing about XPeng as xpeng stock winning this week suggests growth catalysts could unfold. This guide...
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
A Minnesota couple on Clark Howard's show discovers their $400,000 80-year term policy no longer fits their growing f...
This in-depth alphabet stock analysis: final piece breaks down Alphabet's earnings, competitive position, and the act...
A six-pill prescription that would cost $1,000 in the United States ends up costing just $25 through an international...